177 related articles for article (PubMed ID: 10221611)
1. Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy.
Piura B; Yanai-Inbar I; Rabinovich A; Zalmanov S; Goldstein J
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):57-61. PubMed ID: 10221611
[TBL] [Abstract][Full Text] [Related]
2. Uterine metastases from breast cancer in a patient under tamoxifen therapy. Case report.
Dessole S; Cherchi PL; Ruiu GA; Meloni GB; Cossu Rocca P
Eur J Gynaecol Oncol; 1999; 20(5-6):416-7. PubMed ID: 10609509
[TBL] [Abstract][Full Text] [Related]
3. Metastatic breast carcinoma manifesting as postmenopausal uterine bleeding in a patient on tamoxifen therapy.
Maymon R; Czernobilsky B; Lifschitz-Mercer B; Schneider D; Bukovsky I; David A
Eur J Gynaecol Oncol; 1996; 17(4):319-21. PubMed ID: 8856316
[TBL] [Abstract][Full Text] [Related]
4. Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer on tamoxifen therapy.
Famoriyo A; Sawant S; Banfield PJ
Arch Gynecol Obstet; 2004 Nov; 270(3):192-3. PubMed ID: 14735373
[TBL] [Abstract][Full Text] [Related]
5. Sigmoid colon carcinoma metastatic to the myometrium.
Walfisch S; Lapid O; Yanai-Inbar I; Piura B
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):65-8. PubMed ID: 10471144
[TBL] [Abstract][Full Text] [Related]
6. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
Liu IF; Yen YS; Cheng YM; Chou CY
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
[TBL] [Abstract][Full Text] [Related]
7. Effects of tamoxifen on the cervix and uterus in women with breast cancer: experience with Iranian patients and a literature review.
Karimi Zarchi M; Behtash N; Sekhavat L; Dehghan A
Asian Pac J Cancer Prev; 2009; 10(4):595-8. PubMed ID: 19827876
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcoma associated with tamoxifen use: case report.
Martin-Loeches M; Rius J; Orti RM
Eur J Gynaecol Oncol; 2003; 24(2):202-3. PubMed ID: 12701980
[TBL] [Abstract][Full Text] [Related]
9. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
[TBL] [Abstract][Full Text] [Related]
10. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
Behtash N; Hashemi R; Karimi Zarchi M
Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
[TBL] [Abstract][Full Text] [Related]
11. Uterine tumor resembling ovarian sex cord tumors in a patient using tamoxifen: report of a case and review of literature.
Oztekin O; Soylu F; Yigit S; Sarica E
Int J Gynecol Cancer; 2006; 16(4):1694-7. PubMed ID: 16884388
[TBL] [Abstract][Full Text] [Related]
12. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
Le Bouëdec G; de Latour M; Dauplat J
Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
[TBL] [Abstract][Full Text] [Related]
13. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of recurrent uterine bleeding during tamoxifen therapy by endometrial ablation.
Römer T
Int J Gynaecol Obstet; 1995 Apr; 49(1):51-2. PubMed ID: 9457985
[TBL] [Abstract][Full Text] [Related]
15. Pathologic quiz case: postmenopausal vaginal bleeding in a woman treated for breast carcinoma.
Martinez AE; Robinson MJ
Arch Pathol Lab Med; 2003 May; 127(5):e261-2. PubMed ID: 12708930
[No Abstract] [Full Text] [Related]
16. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
Reslová T; Tosner J; Vávrová I; Resl M
Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
[TBL] [Abstract][Full Text] [Related]
17. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
18. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial.
Gardner FJ; Konje JC; Abrams KR; Brown LJ; Khanna S; Al-Azzawi F; Bell SC; Taylor DJ
Lancet; 2000 Nov; 356(9243):1711-7. PubMed ID: 11095258
[TBL] [Abstract][Full Text] [Related]
19. Lobular breast cancer metastasis to uterus during adjuvant tamoxifen treatment: A case report and review of the literature.
Aytekin A; Bilgetekin I; Ciltas A; Ogut B; Coskun U; Benekli M
J Cancer Res Ther; 2018; 14(5):1135-1137. PubMed ID: 30197363
[TBL] [Abstract][Full Text] [Related]
20. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
Suprasert P; Khunamornpong S
J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
